Firms

Luma Group

Luma Group

lumagroup.com

Luma Group is a New York investment firm backing biotechnology companies from early discovery through clinical development and commercialization. It combines biological research and computational analysis to evaluate therapies, diagnostics and medical devices, and supports portfolio companies with scientific and operational expertise. Its LABI AI system helps analyze research data and assess scientific breakthroughs. LumaBio Fund I closed at $410 million in September 2026 and has a 15-year investment structure.

Founded
—
Type
Venture capital

Funds1

  • LumaBio Fund I$410M

    Inaugural life sciences venture fund, legally LumaBio I LP, with a $410 million final close announced on 9 September 2026. A 15-year vehicle that invests early and can support portfolio companies from discovery through commercialization. Began investing in 2023; 2023 inception is separate from this 2026 final close.

Team

Negin Mokhtari
Negin Mokhtari

Luma Group, Venture Partner & Chief Strategy Officer of LABI

—— – —

Operations and support

Bill RyanChief Financial Officer
James StankowiczHead of AI & Engineering
Jamie KasuboskiPartner & Head of Research
John GomezSenior Associate
Josh FinkFounder & Managing Member
Nora McCarthyAdministrative Assistant
Richard EbrightScience Fellow
Richie SantryChief of Staff
Rishabh MishraClinical Advisor
Rosana KapellerVenture Partner
Tamara YoungExecutive Assistant
Themasap KhanCo-Founder & Partner

Co-investing

Investments